Great Bay Bio Ltd. is a biotechnology company based in Central Hong Kong, founded in 2002. The company specializes in drug discovery and contract research services, leveraging artificial intelligence within its Chemistry, Manufacturing, and Control (CMC) platform to enhance drug development processes. Great Bay Bio is involved in the research, development, and manufacturing of protein sequence products, including recombinant insulin-stimulating hormones and fusion proteins. With a focus on biopharmaceutical innovation, the company utilizes a digital platform that integrates AI technology, big data, and Internet of Things technology to streamline the drug development cycle and reduce costs. By aligning with national strategies for scientific innovation and fostering collaboration across regions such as Europe, the United States, Singapore, and Hong Kong, Great Bay Bio aims to enhance its competitive edge in the biopharmaceutical industry.
Everbright Water is one of China's leading integrated water environment management companies. Its main business includes: integrated water environment management, sponge city construction, watershed management, water supply, sewage treatment, water reuse, sewage source heat pump, sludge treatment and disposal. Environmental water technology research and development and engineering construction, the business is distributed in East China, Central China, South China, North China, Northeast China and Northwest China, including Beijing, Jiangsu, Shandong, Shaanxi, Henan, Hubei, Guangxi, Liaoning, Inner Mongolia and other provinces and autonomous regions. As of December 31, 2018, the design scale of the water treatment project for the construction and operation management of Everbright Water was over 5 million cubic meters per day.